Leaderboard

En | De
Sie sind hier: Gastroenterologie » Oesophagus » Neoplasie 21. Februar 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Magen-Darm
Oesophagus
Motilitätsstörungen
Neoplasie
Anderes
Pankreas
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 1915  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 38298  
   
Serum superoxide dismutase activity and risk of esophageal cancer in a nested case-control study.
Jpn J Clin Oncol
Adachi Y, Nojima M, Lin Y, Sasaki Y, Yamano HO, Nakase H, Wakai K, Mori M, Tamakoshi A, for Japan Collaborative Cohort (JACC) study.
PMID: 41718680 [PubMed - as supplied by publisher]


Patient-Reported Symptom Recovery After Upper Gastrointestinal Cancer Surgery: A Prospective Study Using the MDASI-UGI-Surg.
Ann Surg Oncol
Tomita K, Smith PM, Takayama M, Pan C, Shen SE, Wang X, Wang XS, Williams LA, Arvide EM, To C, Rajaram R, Mitchell KG, Rice DC, Hofstetter WL, Antonoff MB, Mehran RJ, Vaporciyan AJ, Walsh GL, Maxwell JE, Snyder RA, Kim MP, Tzeng CD, Mansfield PF, Swisher SG, Lee JE, Badgwell BD, Katz MHG, Ikoma N.
PMID: 41714832 [PubMed - as supplied by publisher]


The consensus molecular subtypes of esophageal squamous cell carcinoma.
Signal Transduct Target Ther
Cui H, Zhu Z, Xu E, Qi L, Cheng Y, Zhang Y, Zhang L, Cheng MY, Yang B, Sun R, Zhuang X, Xi Y, Yan T, Cheng C, Ding N, Liu H, Wang L, Guo M, Guo D, Zhang H, Peng M, An Z, Weng Y, Wang F, Liu M, Xiong R, Yin W, Song B, Zhang W, Cheng X, Liu Z, Zhan Q, Wang X, Cui Y.
PMID: 41714596 [PubMed - indexed for MEDLINE]


Relationship between the microbiome and obesity-associated cancer risk using Mendelian randomisation.
Int J Obes (Lond)
Yates T, Went M, Mills C, Law P, Houlston R.
PMID: 41714395 [PubMed - as supplied by publisher]


Randomized Study on Different Radiation Doses in Neoadjuvant Chemoradiotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma (Neo-DRATEC Trial).
Int J Radiat Oncol Biol Phys
Yang Y, Jiang Y, Wang C, Li J, Zhou X, Bao W, Chen M, Tao K, Wu J, Wang S, Ruan R, Tao Y, Song G, Li R, Wang L, Su D, Qiu G, Chen Q.
PMID: 41713514 [PubMed - as supplied by publisher]


Influence of stage at cancer diagnosis on NHS hospital care costs in England: a national, retrospective, population-based cohort study using individual patient-level data.
Lancet Oncol
Pearson C, Jones DA, Baily G, Cherry R, Gray E, Hiom S, Rous B, Spencer K, Jose S.
PMID: 41713471 [PubMed - as supplied by publisher]


TRIM59 (Tripartite Motif-Containing 59) Expression in Pan-Cancer and Its Diagnostic and Prognostic Implications in Breast Cancer, Esophageal Cancer, Lung Squamous Cell Carcinoma, and Stomach Adenocarcinoma.
Cureus
Attaelmanan GA, Fateh Alrhman MY, Abdelrahman DN, Mohamed T, Elkhidir M, Mohamed RR, Hamad H, Mohamed M, Siddig E, Muzzammil M, Alfaki M.
PMID: 41710851 [PubMed]


Establishing a standard surgery for esophagogastric junction cancer: Final results from the JGCA-JES nationwide prospective study.
Cell Rep Med
Kurokawa Y, Takeuchi H, Doki Y, Mine S, Terashima M, Yasuda T, Yoshida K, Daiko H, Sakuramoto S, Yoshikawa T, Kunisaki C, Seto Y, Tamura S, Shimokawa T, Sano T, Kitagawa Y.
PMID: 41707650 [PubMed - indexed for MEDLINE]


Preoperative Circulating Tumor DNA Detection and Risk Stratification in Esophageal Squamous Cell Carcinoma.
JAMA Surg
Hong TH, Jeong JG, Park SY, Park BJ, Kyung D, Kim HP, Zhu J, Yang YH, Kim HE, Lee CY, Lee JG, Jeon YJ, Lee J, Cho JH, Choi YS, Shim YM, Lee SH, Kim DJ, Kim HK.
PMID: 41706468 [PubMed - as supplied by publisher]


Platelet-to-lymphocyte ratio for prognostication in immune checkpoint inhibitor-treated cancer patients: a meta-analysis of 13027 patients highlighting nivolumab-responsive renal cell carcinoma.
Front Immunol
Wang M, Dong W, Chen J, Wu P, Wang Y, Zhang X, Cao Y, Wang Z, Zhong Z, Zhong Y.
PMID: 41705252 [PubMed - indexed for MEDLINE]


Automated tumor regression grade assessment and survival prediction in esophageal cancer via weakly supervised multiple instance learning.
Front Med (Lausanne)
Liu Z, Zhao L, Zhao Z, Qin W, Zhong J, Lin F, Lu M, Guo R, Guo Q, Xu H, Li S, Zheng H, Lu H.
PMID: 41704702 [PubMed]


G protein-coupled receptor 137B drives malignant progression and May serves as a diagnostic and prognostic biomarker in esophageal squamous cell carcinoma.
Cancer Cell Int
Guo R, Li Y, Yi Z, Zhang W, Wang H, Wang Y, Li X, Song J.
PMID: 41703585 [PubMed - as supplied by publisher]


MDPNet: a multi-scale difference perception network for esophageal cancer segmentation in CT images.
BMC Med Imaging
Qi F, Ye Q, Xu C, Wang J, Gao L.
PMID: 41703480 [PubMed - as supplied by publisher]


Neutrophil-to-lymphocyte ratio in unresectable or metastatic esophageal squamous cell carcinoma: a systematic review, meta-analysis and meta-regression.
Clin Transl Oncol
Colloca GA, Venturino A.
PMID: 41703395 [PubMed - as supplied by publisher]


Nutritional and prognostic effects of thoracic duct obliteration during esophagectomy.
Dis Esophagus
Liu C, Lee YY, Chien LI, Tao ZX, Huang CS, Hsu HS, Hsu WH, Hsu PK.
PMID: 41701635 [PubMed - indexed for MEDLINE]


Survival After Pathological Complete Response Following Neoadjuvant Chemotherapy vs Chemoradiotherapy in Esophageal Squamous Cell Carcinoma.
Br J Surg
Okui J, Matsuda S, Nagashima K, Sato Y, Kawakubo H, Ruhstaller T, Thuss-Patience P, Nilsson M, Klevebro F, Tan L, Zhang S, Aparicio T, Piessen G, van der Zijden C, Mostert B, Wijnhoven BPL, Tsushima T, Takeuchi H, Kato K, Kitagawa Y.
PMID: 41699916 [PubMed - as supplied by publisher]


Mucosal Versus Submucosal Lymphovascular Invasion in Early Esophageal Cancer.
Ann Surg Oncol
Deboever N, Khanduri I, Eisenberg M, Mehran RJ, Rajaram R, Rice DC, Roth J, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB, Maru DM, Hofstetter WL.
PMID: 41699354 [PubMed - as supplied by publisher]


Multilevel pathways to esophageal cancer: Population attributable risks of modifiable exposures, surrogate blood biomarkers, and genetic susceptibility, and the mediation effects based on a 10-year prospective cohort study.
Int J Cancer
Cui Z, Zhao Y, Xu Q, Zhao R, Yuan H, Zhang T, Suo C, Chen X.
PMID: 41696916 [PubMed - as supplied by publisher]


The role of thoracic radiotherapy in the setting of immunotherapy in polymetastatic esophageal squamous cell carcinoma: a multi-center cohort study.
Ther Adv Med Oncol
Liu Q, Chen J, Shen W, Ye J, Luo H, Zhang X, Liu W, Xu Y, Zhang Y, Liu A, Li X, Ge H, Wang Q, Luo H, Zhao L, Xie C, Lin Q, Xie C, Wang L, Zhao K.
PMID: 41696558 [PubMed]


Ethnic genomic diversity in esophageal squamous cell carcinoma.
World J Gastrointest Oncol
Li WM, Jiao Y, Liu SQ, Wang CX, He M.
PMID: 41695932 [PubMed]


   
   Artikel 1 - 20 / 38298    Seite 1 von 1915  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1